Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John F. Milligan Insider Profile
11 Followers
John F. Milligan, President & CEO, Director at Gilead Sciences, holds 100.00K shares in 4D Molecular Therapeutics (Ticker: FDMT), holds 110.00K shares in Pacific Biosciences (Ticker: PACB), holds 1.57M shares in Gilead Sciences (Ticker: GILD). Most recently, John F. Milligan Bought ― shares of 4D Molecular Therapeutics on Dec 17, 2020 for an estimated value of 2.30M.
John F. Milligan Gilead Sciences (GILD)President & CEO, Director
Gilead Sciences (GILD)
President & CEO, Director
Ranked #1,430 out of 98,564 Corporate Insiders
Profitable Transactions
24 out of 26 Profitable Transactions
Average Return
+25.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John F. Milligan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 26, 2020 - Aug 26, 2021
Return:+336.10%
The most profitable trade made by John F. Milligan
John F. Milligan's Trading History
Gilead Sciences
Nov 29, 2018
President & CEO, Director
Informative Buy
6.61M
$105.53M
4D Molecular Therapeutics
Dec 17, 2020
Director
Informative Buy
2.30M
$2.48M
Pacific Biosciences
Aug 26, 2020
Director
Informative Buy
365.20K
$161.70K
List of latest transactions for each holding click on a transaction to see John F. Milligan's performance on stock
You May Also Like
John F. Milligan insider profile FAQ
What is the percentage of profitable transactions made by John F. Milligan?
The percentage of profitable transactions made by John F. Milligan is 92%.
What is the average return per transaction made by John F. Milligan?
The average return per transaction made by John F. Milligan is 25.30%.
What stocks does John F. Milligan hold?
John F. Milligan holds: GILD, FDMT, PACB stocks.
What was John F. Milligan’s latest transaction?
John F. Milligan latest transaction was an Informative Buy of $2.30M.
What was John F. Milligan's most profitable transaction?
John F. Milligan’s most profitable transaction was an Informative Buy of PACB stock on August 26, 2020. The return on the trade was 336.10%.
What is John F. Milligan's role in Gilead Sciences?
John F. Milligan's role in Gilead Sciences is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.